Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Genoway

ALGEN
Current price
3.62 EUR +0.16 EUR (+4.62%)
Last closed 3.46 EUR
ISIN FR0004053510
Sector Healthcare
Industry Biotechnology
Exchange Euronext Paris
Capitalization 29 505 239 EUR
Yield for 12 month -12.14 %
1Y
3Y
5Y
10Y
15Y
ALGEN
21.11.2021 - 28.11.2021

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France. Address: Technopark 2, Lyon, France, 69007

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.21 EUR

P/E ratio

17.2381

Dividend Yield

Current Year

+20 118 021 EUR

Last Year

+17 114 454 EUR

Current Quarter

+10 748 479 EUR

Last Quarter

+10 752 891 EUR

Current Year

+20 172 215 EUR

Last Year

-1 314 816 EUR

Current Quarter

+10 748 479 EUR

Last Quarter

+10 807 085 EUR

Key Figures ALGEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 5 564 626 EUR
Operating Margin TTM 3.67 %
PE Ratio 17.2381
Return On Assets TTM 2.45 %
PEG Ratio
Return On Equity TTM 7.2 %
Wall Street Target Price 6.21 EUR
Revenue TTM 28 183 066 EUR
Book Value 1.84 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 13.5 %
Dividend Yield
Gross Profit TTM 10 241 471 EUR
Earnings per share 0.21 EUR
Diluted Eps TTM 0.21 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin 4.47 %

Dividend Analytics ALGEN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALGEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ALGEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 17.2381
Forward PE
Enterprise Value Revenue 1.3822
Price Sales TTM 1.0469
Enterprise Value EBITDA 4.8414
Price Book MRQ 1.5803

Financials ALGEN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALGEN

For 52 weeks

3.25 EUR 4.93 EUR
50 Day MA 3.71 EUR
Shares Short Prior Month
200 Day MA 4.01 EUR
Short Ratio
Shares Short
Short Percent